95 -11 (73) 2024 - Kochieva A.M. - MODERN POSSIBILITIES OF DIAGNOSTICS OF UTERINE FIBROIDS

MODERN POSSIBILITIES OF DIAGNOSTICS OF UTERINE FIBROIDS

Kochieva A.M. - Tashkent Pediatric Medical Institute

Resume

Uterine fibroids are the leading cause of morbidity in women of reproductive age (and sometimes after menopause). There are several factors underlying the development and incidence of these common tumors, but this once again confirms their relatively unexplored etiology. The gold standard for diagnosing uterine fibroids is serogradient ultrasound, and magnetic resonance imaging is the second option in complex clinical situations. This article presents an analysis of the literature on the diagnostic aspects of uterine fibroids.

Keywords: Uterine fibroids, ultrasound, MRI.

First page

549

Last page

554

For citation:Kochieva A.M. - MODERN POSSIBILITIES OF DIAGNOSTICS OF UTERINE FIBROIDS//New Day in Medicine 11(73)2024 549-554 https://https://newdayworldmedicine.com/en/new_day_medicine/11-73-2024

List of References

  1. Нарзуллоева Н. С., Неъматова М. Р. Иммунологические Ответи У Женщин В Пременопаузальним Периода С Миомой Матки //Amaliy va tibbiyot fanlari ilmiy jurnali. – 2022;1(6):301-307.
  2. Юлдашева О.С. и др. Состояние репродуктивной функции у женщин с миомой матки (обзор литературы) //Молодой ученый. 2016;4:312-315.
  3. Нарзуллаева Н. С. и др. Клинические и иммунологические аспекты миомы матки в сочетании с различными инфекциями //Редакционная коллегия. 2018; с.232.
  4. Штох Е. А., Цхай В. Б. Миома матки. Современное представление о патогенезе и факторах риска //Сибирское медицинское обозрение. 2015;1(91):22-27.
  5. Радзинский В. Е., Архипова М. П. Миома матки: проблемы и перспективы начала века //Медицинский совет. 2014;9:30-33.
  6. Подзолкова Н. М., Коренная В. В., Колода Ю. А. Миома матки. – 2015.
  7. Доброхотова Ю. Э., Ильина И. Ю., Гончаров И. Ю. Миома матки. Безоперационное лечение //РМЖ. 2018;26(2-1):3-6.
  8. Шрамко С. В. и др. Биологические маркеры клеточного цикла Ki-67 и Bcl-2 при миоме, аденомиозе и лейомиосаркоме матки //Медицина в Кузбассе. 2019;18(3):20-24.
  9. Medikare V. et al. The genetic bases of uterine fibroids; a review //Journal of reproduction infertility. 2011;12(3):181.
  10. McWilliams M. M., Chennathukuzhi V. M. Recent advances in uterine fibroid etiology //Seminars in reproductive medicine. – Thieme Medical Publishers, 2017;35(2):181-189.
  11. Jamaluddin M. F. B., Nahar P., Tanwar P. S. Proteomic characterization of the extracellular matrix of human uterine fibroids //Endocrinology. 2018;159(7):2656-2669.
  12. Khan A. T., Shehmar M., Gupta J. K. Uterine fibroids: current perspectives //International journal of women's health. 2014; с.95-114.
  13. Weinreb J. C. et al. The value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminate //AJR. American journal of roentgenology. 2010;154(2):295-299.
  14. Ciarmela P. et al. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications //Human reproduction update. 2011;17(6):772-790.
  15. Török P., Póka R. Diagnosis and treatment of uterine myoma //Orvosi Hetilap. 2016;157(21):813-819.
  16. Ciebiera M. et al. Role of transforming growth factor β in uterine fibroid biology //International Journal of Molecular Sciences. 2017;18(11):2435.
  17. Jamaluddin M. F. B. et al. Proteomic profiling of human uterine fibroids reveals upregulation of the extracellular matrix protein periostin //Endocrinology. 2018;159(2):1106-1118.
  18. Halder S. K., Osteen K. G., Al-Hendy A. 1, 25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells //Biology of reproduction. 2013;89(6):1-13.
  19. Aleksandrovych V. et al. Uterine fibroid: common features of widespread tumor //Folia medica Cracoviensia. 2015;55(1).
  20. Styer A. K., Rueda B. R. The epidemiology and genetics of uterine leiomyoma //Best practice research Clinical obstetrics gynaecology. 2016;34:3-12.

    file

    download